os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Yorr Kirisar
Country: Belize
Language: English (Spanish)
Genre: Automotive
Published (Last): 15 September 2004
Pages: 436
PDF File Size: 7.26 Mb
ePub File Size: 5.84 Mb
ISBN: 940-4-50132-232-6
Downloads: 2524
Price: Free* [*Free Regsitration Required]
Uploader: Shaktiramar

J Am Dent Assoc ; Oncol Nurs Forum ; Osteonecrosis associated with the use of biphosphonates: A report of 2 cases.

Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral

The presence of other risk factors should be taken into account, and patients should be surveilled on an individual basis for the potential odojtologia of heart rhythm disturbances. Patients with bisphosphonates-associated osteonecrosis of the jaw have reduced circulating endothelial cells.

Effects of drugs and systemic factors on orthodontic treatment.

Pirophosphate is the simplest form of phosphate. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.


Models for the pathogenesis of stress fractures in athletes. Mineralization disturbances of the developing rat molar induced by mono- and bisphosphonates. Severely suppressed bone turnover: Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: Rev Esp Cir Oral Maxilofac ; 30 3: Netherlands Pharmacovigilance Centre, Bisphosphonates and estomatitis. Posso extrair um dente? No tests are available that allow an identification of patients at higher risk for developing MON in order to adopt appropriate preventive measures.

Abstract In recent years, due to different causes, an increasing number of patients are under medical treatment with bisphosphonates. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Reid IR, Cundy T. The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. The purpose of this review is to describe the characteristics of bisphosphonates, its mechanism of action, clinical manifestation of osteonecrosis of the jaws, therapeutic management and prevention.

Ambos grupos conllevan a la muerte celular programada del osteoclasto apoptosis. Multiple ulcerative esophagitis caused by alendronate. J Clin Endocrinol Metab, 92pp. Los odonhologia y las fracturas por fatiga.


The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. El manejo de las lesiones es de alta complejidad.

J Am Dent Assoc,pp. Orthodontic treatment of patients using bisphosphonates: Novel antiogenic effects of the bisphosphonate compound Zoledronic acid. Vidal 1C. Br J Ophthalmol ; A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects — maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders.

Patients treated with intravenous nitrogen-containing bisphosphonates, have a major risk to develop osteonecrosis.

Hospital de Jerez de la Frontera.